The FDA granted orphan drug designation to a CAR T-cell therapy for recurrent glioblastoma and high-grade astrocytomas.

A cancer thriver reflects on the emotional toll, survivorship, advocacy and support networks they wish they’d known at ...

I’ve survived rare blood cancer for 15 years, but the lasting side effects have taken a toll — even so, I still find purpose, ...

New clinical trials are advancing in hard-to-treat cancers, offering targeted and less toxic options for patients with ...

It took years to understand why my mastectomy site looked different. Knowing I healed correctly for my procedure helped me ...

The FDA approved SIR-Spheres Y-90 resin microspheres for unresectable liver cancer, the only radioembolization approved in ...

Dr. Nicholas James discusses why it is important to identify which patients with high-risk prostate cancer will truly benefit ...